Carl Zeiss Meditec AG
Company Profile
Business description
Carl Zeiss Meditec is one of the largest medical technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
Contact
Goschwitzer Strasse 51-52
JenaTH07745
DEUT: +49 3641220115
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
30 September 2025
Employees
5,730
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,704.40 | 180.10 | 2.39% |
| CAC 40 | 7,172.82 | 245.70 | 3.55% |
| DAX 40 | 20,453.34 | 663.72 | 3.35% |
| Dow JONES (US) | 39,394.56 | 1,428.96 | 3.76% |
| FTSE 100 | 7,969.98 | 267.90 | 3.48% |
| HKSE | 20,127.68 | 299.38 | 1.51% |
| NASDAQ | 16,300.51 | 697.25 | 4.47% |
| Nikkei 225 | 33,012.58 | 1,876.00 | 6.03% |
| NZX 50 Index | 11,891.44 | 115.56 | 0.98% |
| S&P 500 | 5,261.82 | 199.57 | 3.94% |
| S&P/ASX 200 | 7,510.00 | 166.70 | 2.27% |
| SSE Composite Index | 3,145.55 | 48.97 | 1.58% |